Biorestorative Therapies (BRTX) Sees 3.9% Rise Amid Low Liquidity & Market Skepticism
Biorestorative Therapies’ stock slides 41% and trades at a fraction of its value, warning investors of liquidity risk and a bearish biotech sector.
- BIORESTORATIVE THERAPIES INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read